Company
United StatesSomerville Acquisitions, Inc., Flemington, NJ – FDA Inspections
Inspection records and compliance data for Somerville Acquisitions, Inc. in Flemington, New Jersey. 5 FDA inspections on record, 1 Form 483, last inspected June 04, 2025.
Company Profile
This profile covers Somerville Acquisitions, Inc. based in Flemington, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 2
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected February 16, 2010. Last inspected June 4, 2025.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 4, 2025 | Not classified | Human Drugs | 1272925 |
| January 30, 2020 | NAI | Human Drugs · Drug Quality Assurance | 1120564 |
| December 3, 2013 | NAI | Human Drugs · Drug Quality Assurance | 857121 |
| August 15, 2011 | VAI | Human Drugs · Drug Quality Assurance | 739753 |
| February 16, 2010 | VAI | Human Drugs · Drug Quality Assurance | 646902 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Huber Soda, LLC
Albemarle US, Inc.
Natco Pharma Ltd. - Chemical Division
Zach System S.A.
Cadila Pharmaceuticals Limited
Aarti Pharmalabs Limited
Wuhan Biocause Pharmaceutical Development Co., Ltd.
Arch Pharmalabs Ltd.
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
Jiangxi Synergy Pharmaceutical, Co., Ltd.
Company Information
Name
Somerville Acquisitions, Inc.
FEI Number
3004099380
Address
45 River Rd, Flemington, New Jersey 08822, United States
Country
United States
ID: 195f0557-96af-4562-98e7-9e03150b33cb